<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03460587</url>
  </required_header>
  <id_info>
    <org_study_id>17IRG3346039</org_study_id>
    <nct_id>NCT03460587</nct_id>
  </id_info>
  <brief_title>Long-term Telerehabilitation for Patients With Stroke</brief_title>
  <official_title>Long-term Telerehabilitation for Patients With Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current protocol is to study 40 patients, each for 12 weeks, to address&#xD;
      hypotheses related to the ability of a telerehabilitation system to (a) improve motor status&#xD;
      and disability, (b) collect various forms of patient data from the home, (c) improve risk&#xD;
      factor knowledge and control, and (d) assess patient compliance with home-based&#xD;
      telerehabilitation.&#xD;
&#xD;
      Patients who have returned to their home after stroke will be provided with a telehealth&#xD;
      system and be asked to use it 6 days/week for 12 weeks, during which time subjects will use&#xD;
      this system for daily rehabilitation therapy, assessments, and education--all on one&#xD;
      platform.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is perennially one of the leading causes of human disability. Stroke is truly a&#xD;
      chronic disease, with survivors living for years or decades after the event. Increasing&#xD;
      evidence describes years of steady decline in several health measures for stroke survivors.&#xD;
      Many factors contribute to this, including further strokes, uncontrolled risk factors,&#xD;
      development of late complications of stroke, and limited access to rehabilitation therapy.&#xD;
&#xD;
      New approaches are needed that address the many needs of stroke survivors, efficiently and in&#xD;
      aggregate. Emerging telehealth technologies have high potential to address this major unmet&#xD;
      need, but substantial innovation will be needed. The long-term goal is to establish a&#xD;
      telehealth platform to treat chronic stroke.&#xD;
&#xD;
      A telehealth system will be delivered to enrollee's home. Patients will be asked to interact&#xD;
      with their system daily (at least 6 days/wk) for 12 weeks. For 3 times per week, during the&#xD;
      first 2 weeks, and then 1 time per week thereafter, a study therapist or research assistant&#xD;
      in the lab will use the telehealth system to have a videoconference with the subject, to&#xD;
      answer questions, provide feedback, review progress, and make any changes needed in the&#xD;
      therapy plan. Study personnel will monitor usage statistics and performance measures for all&#xD;
      systems.&#xD;
&#xD;
      A key strategy is to measure in parallel, patient behaviors in three categories of health&#xD;
      issues central to chronic stroke: (1) medical management issues including risk factor&#xD;
      knowledge and control, (2) disability issues including motor function, and (3) psychological&#xD;
      issues including depression and anxiety.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 29, 2018</start_date>
  <completion_date type="Actual">March 31, 2019</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer Arm Motor Scale</measure>
    <time_frame>90 days</time_frame>
    <description>measure of arm impairment, scores range from 0 to 66 with higher numbers reflecting less arm impairment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Leg Motor Scale</measure>
    <time_frame>90 days</time_frame>
    <description>measure of leg impairment, scores range from 0 to 34 with higher numbers reflecting less leg impairment</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Stroke</condition>
  <condition>Cerebrovascular Disorders</condition>
  <condition>Brain Diseases</condition>
  <condition>Central Nervous System Diseases</condition>
  <condition>Nervous System Diseases</condition>
  <condition>Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>Home-based Telerehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Home-based Telerehabilitation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telerehabilitation</intervention_name>
    <description>The Telerehabilitation system will deliver rehabilitation treatment sessions via an in-home internet-connected computer. A major component of the system is the use of games to promote therapeutically relevant movements. The subject will perform daily assigned home-based telerehabilitation games and exercises and 5 minutes of stroke education, all guided by the telerehabilitation system.During some of the sessions, therapists will initiate a videoconference with the subject's telerehabilitation system to discuss progress, issues, and revise treatment plans as needed.</description>
    <arm_group_label>Home-based Telerehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age â‰¥18 years at the time of randomization&#xD;
&#xD;
          2. Stroke that is radiologically verified, due to ischemia or to intracerebral hemorrhage&#xD;
             or subarachnoid hemorrhage, and with any time of stroke onset prior to randomization&#xD;
&#xD;
          3. Arm motor Fugl Meyer score of 28-66; if Arm motor Fugl Meyer score&gt; 59, must also have&#xD;
             Box &amp; Blocks on affected side &gt;25% lower&#xD;
&#xD;
          4. Box &amp; Block Test score with affected arm is at least 3 blocks in 60 seconds at the&#xD;
             first visit&#xD;
&#xD;
          5. Informed consent signed by the subject&#xD;
&#xD;
          6. Behavioral contract signed by the subject&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. A major, active, coexistent neurological or psychiatric disease, including alcoholism&#xD;
             or dementia&#xD;
&#xD;
          2. A diagnosis (apart from the index stroke) that substantially affects paretic arm&#xD;
             function&#xD;
&#xD;
          3. A major medical disorder that substantially reduces the likelihood that a subject will&#xD;
             be able to comply with all study procedures&#xD;
&#xD;
          4. Severe depression, defined as Geriatric Depression Scale Score &gt;11&#xD;
&#xD;
          5. Significant cognitive impairment, defined as Montreal Cognitive Assessment score &lt; 22;&#xD;
             note that this exclusion criteria can be waived at the discretion of the study PI,&#xD;
             e.g., for aphasia&#xD;
&#xD;
          6. Deficits in communication that interfere with reasonable study participation&#xD;
&#xD;
          7. Lacking visual acuity, with or without corrective lens, of 20/40 or better in at least&#xD;
             one eye&#xD;
&#xD;
          8. Life expectancy &lt; 6 months&#xD;
&#xD;
          9. Receipt of Botox to arms, legs, or trunk in the preceding 6 months, or expectation&#xD;
             that Botox will be administered to the arm, leg, or trunk prior to completion of&#xD;
             participation in this study&#xD;
&#xD;
         10. Unable to successfully perform all 3 of the rehabilitation exercise test examples&#xD;
&#xD;
         11. Unable or unwilling to perform study procedures/therapy, or expectation of&#xD;
             non-compliance with study procedures/therapy, or expectation that subject will be&#xD;
             unable to participate in study visits&#xD;
&#xD;
         12. Concurrent enrollment in another investigational study&#xD;
&#xD;
         13. Non-English speaking, such that subject does not speak sufficient English to comply&#xD;
             with study procedures&#xD;
&#xD;
         14. Expectation that subject will not have a single domicile address during the 12 weeks&#xD;
             of therapy, within 75 miles of the central study site&#xD;
&#xD;
         15. Note that the presence of wireless home internet connectivity is not an exclusion&#xD;
             criterion, but preference may be given to enrollees who do have wireless home internet&#xD;
             connectivity because this will enable testing of study hypotheses.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Cramer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Irvine</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dodakian L, McKenzie AL, Le V, See J, Pearson-Fuhrhop K, Burke Quinlan E, Zhou RJ, Augsberger R, Tran XA, Friedman N, Reinkensmeyer DJ, Cramer SC. A Home-Based Telerehabilitation Program for Patients With Stroke. Neurorehabil Neural Repair. 2017 Oct-Nov;31(10-11):923-933. doi: 10.1177/1545968317733818. Epub 2017 Oct 26.</citation>
    <PMID>29072556</PMID>
  </reference>
  <reference>
    <citation>Cramer SC, Sur M, Dobkin BH, O'Brien C, Sanger TD, Trojanowski JQ, Rumsey JM, Hicks R, Cameron J, Chen D, Chen WG, Cohen LG, deCharms C, Duffy CJ, Eden GF, Fetz EE, Filart R, Freund M, Grant SJ, Haber S, Kalivas PW, Kolb B, Kramer AF, Lynch M, Mayberg HS, McQuillen PS, Nitkin R, Pascual-Leone A, Reuter-Lorenz P, Schiff N, Sharma A, Shekim L, Stryker M, Sullivan EV, Vinogradov S. Harnessing neuroplasticity for clinical applications. Brain. 2011 Jun;134(Pt 6):1591-609. doi: 10.1093/brain/awr039. Epub 2011 Apr 10.</citation>
    <PMID>21482550</PMID>
  </reference>
  <reference>
    <citation>Kwakkel G, Wagenaar RC, Twisk JW, Lankhorst GJ, Koetsier JC. Intensity of leg and arm training after primary middle-cerebral-artery stroke: a randomised trial. Lancet. 1999 Jul 17;354(9174):191-6.</citation>
    <PMID>10421300</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2018</study_first_posted>
  <results_first_submitted>June 11, 2020</results_first_submitted>
  <results_first_submitted_qc>November 22, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 17, 2020</results_first_posted>
  <last_update_submitted>November 22, 2020</last_update_submitted>
  <last_update_submitted_qc>November 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Steven C. Cramer, MD</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Central Nervous System Diseases</mesh_term>
    <mesh_term>Cerebrovascular Disorders</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 22, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT03460587/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 22, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT03460587/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Home-based Telerehabilitation</title>
          <description>Home-based Telerehabilitation&#xD;
Telerehabilitation: The Telerehabilitation system will deliver rehabilitation treatment sessions via an in-home internet-connected computer. A major component of the system is the use of games to promote therapeutically relevant movements. The subject will perform daily assigned home-based telerehabilitation games and exercises and 5 minutes of stroke education, all guided by the telerehabilitation system.During some of the sessions, therapists will initiate a videoconference with the subject's telerehabilitation system to discuss progress, issues, and revise treatment plans as needed.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All patients who signed informed consent.</population>
      <group_list>
        <group group_id="B1">
          <title>Home-based Telerehabilitation</title>
          <description>Home-based Telerehabilitation&#xD;
Telerehabilitation: The Telerehabilitation system will deliver rehabilitation treatment sessions via an in-home internet-connected computer. A major component of the system is the use of games to promote therapeutically relevant movements. The subject will perform daily assigned home-based telerehabilitation games and exercises and 5 minutes of stroke education, all guided by the telerehabilitation system.During some of the sessions, therapists will initiate a videoconference with the subject's telerehabilitation system to discuss progress, issues, and revise treatment plans as needed.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61" lower_limit="52" upper_limit="65.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time post-stroke</title>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="129" lower_limit="52" upper_limit="486"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Arm motor Fugl-Meyer score</title>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" lower_limit="42" upper_limit="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Leg motor Fugl-Meyer score</title>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28" lower_limit="23.5" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fugl-Meyer Arm Motor Scale</title>
        <description>measure of arm impairment, scores range from 0 to 66 with higher numbers reflecting less arm impairment</description>
        <time_frame>90 days</time_frame>
        <population>All patients who signed informed consent.</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Telerehabilitation</title>
            <description>Home-based Telerehabilitation&#xD;
Telerehabilitation: The Telerehabilitation system will deliver rehabilitation treatment sessions via an in-home internet-connected computer. A major component of the system is the use of games to promote therapeutically relevant movements. The subject will perform daily assigned home-based telerehabilitation games and exercises and 5 minutes of stroke education, all guided by the telerehabilitation system.During some of the sessions, therapists will initiate a videoconference with the subject's telerehabilitation system to discuss progress, issues, and revise treatment plans as needed.</description>
          </group>
        </group_list>
        <measure>
          <title>Fugl-Meyer Arm Motor Scale</title>
          <description>measure of arm impairment, scores range from 0 to 66 with higher numbers reflecting less arm impairment</description>
          <population>All patients who signed informed consent.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59" lower_limit="52.5" upper_limit="61.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fugl-Meyer Leg Motor Scale</title>
        <description>measure of leg impairment, scores range from 0 to 34 with higher numbers reflecting less leg impairment</description>
        <time_frame>90 days</time_frame>
        <population>All patients who signed informed consent</population>
        <group_list>
          <group group_id="O1">
            <title>Home-based Telerehabilitation</title>
            <description>Home-based Telerehabilitation&#xD;
Telerehabilitation: The Telerehabilitation system will deliver rehabilitation treatment sessions via an in-home internet-connected computer. A major component of the system is the use of games to promote therapeutically relevant movements. The subject will perform daily assigned home-based telerehabilitation games and exercises and 5 minutes of stroke education, all guided by the telerehabilitation system.During some of the sessions, therapists will initiate a videoconference with the subject's telerehabilitation system to discuss progress, issues, and revise treatment plans as needed.</description>
          </group>
        </group_list>
        <measure>
          <title>Fugl-Meyer Leg Motor Scale</title>
          <description>measure of leg impairment, scores range from 0 to 34 with higher numbers reflecting less leg impairment</description>
          <population>All patients who signed informed consent</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="27" upper_limit="30.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From enrollment to 90 days later</time_frame>
      <desc>All adverse events and serious adverse events were recorded.</desc>
      <group_list>
        <group group_id="E1">
          <title>Home-based Telerehabilitation</title>
          <description>Home-based Telerehabilitation&#xD;
Telerehabilitation: The Telerehabilitation system will deliver rehabilitation treatment sessions via an in-home internet-connected computer. A major component of the system is the use of games to promote therapeutically relevant movements. The subject will perform daily assigned home-based telerehabilitation games and exercises and 5 minutes of stroke education, all guided by the telerehabilitation system.During some of the sessions, therapists will initiate a videoconference with the subject's telerehabilitation system to discuss progress, issues, and revise treatment plans as needed.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Steven C. Cramer, MD</name_or_title>
      <organization>UCLA</organization>
      <phone>424-522-7273</phone>
      <email>sccramer@mednet.ucla.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

